Special Issue "Oxidative Stress in Diabetic Retinopathy"
A special issue of Antioxidants (ISSN 2076-3921).
Deadline for manuscript submissions: closed (31 July 2020).
A printed edition of this Special Issue is available here.
Interests: diabetic retinopathy; oxidative stress; inflammation; vascular dysfunction; natural antioxidants; exosomes; early biomarkers of diabetic retinopathy
Diabetic retinopathy is an asymptomatic and progressive microvascular complication of diabetes. The increase in the prevalence of diabetic retinopathy acquires special importance, because it is the main cause of loss of vision of the active population and causes a high personal and social impact. Although diabetic retinopathy has a complex etiology, the oxidative stress induced by hyperglycemia is a key factor in retinal damage and diabetic retinopathy development. In fact, many in vitro and in vivo studies have shown the capacity of antioxidants to inhibit, delay or prevent the retinal oxidative damage induced by diabetes. In recent years, new therapeutic strategies have been developed to delay diabetic retinopathy progression in advanced stages; however, damage to retinal blood vessels and neuronal functions in early stages is irreversible. Therefore, a complete understanding of the developmental factors involved and new targets and therapies are needed to prevent or treat retinal damage induced by hyperglycemia.
We invite authors to contribute clinical trials, original research articles or reviews papers focused on the role of oxidative stress in the pathogenesis of diabetic retinopathy and the relationship with intercellular communication, systemic influence on the development of diabetic retinopathy, identification of molecular biomarkers for early diagnosis, exploration of new targets, and effective antioxidant and anti-inflammatory therapies.
Dr. Ángel Luis Ortega
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Diabetic retinopathy
- Natural antioxidants
- Oxidative stress
- Intercellular communication
- Epigenetic mechanisms